MedPath

Capnography During Percutaneous Endoscopic Gastrostomy (PEG)

Phase 3
Conditions
In the Study the Value of Capnography for Avoiding Complications During Sedation for PEG is Evaluated.
Interventions
Device: Capnography
Device: Standard monitoring
Registration Number
NCT01242358
Lead Sponsor
Ruhr University of Bochum
Brief Summary

In this randomized controlled trial the utility of capnography gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
170
Inclusion Criteria
  • 18 Years and older
  • Scheduled for PEG with propofol sedation
Exclusion Criteria
  • No informed consent
  • ASA V
  • Emergency endoscopy
  • Preexisting hypotension, bradycardia or hypoxemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CapnographyCapnographyArm with capnographic monitoring
Standard monitoringStandard monitoringStandard monitoring
Primary Outcome Measures
NameTimeMethod
HypoxemiaFrom the beginning to the end of the PEG procedure, i.e. from 0h to approximately 2h
Secondary Outcome Measures
NameTimeMethod
Further complicationsFrom the beginning to the end of the PEG procedure, i.e. from 0h to approximately 2h

Trial Locations

Locations (3)

Deutsche Klinik für Diagnostik

🇩🇪

Wiesbaden, Germany

Ruhr Universität Bochum

🇩🇪

Bochum, Germany

Technische Universität München

🇩🇪

München, Germany

© Copyright 2025. All Rights Reserved by MedPath